Double maintains 4 strategies that include SRPT - Sarepta Therapeutics, Inc.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
ARWR | 36.92% | $1.74B | -52.08% | 0.00% |
RCKT | 34.52% | $671.77M | -75.23% | 0.00% |
GYRE | 30.75% | $612.10M | -58.68% | 0.00% |
IMNM | 28.28% | $583.44M | -68.94% | 0.00% |
YMAB | 27.91% | $217.05M | -66.71% | 0.00% |
OCUL | 27.74% | $1.17B | -13.14% | 0.00% |
FATE | 27.34% | $88.24M | -89.02% | 0.00% |
PTCT | 27.11% | $3.81B | +66.79% | 0.00% |
PRTA | 27.01% | $653.46M | -49.96% | 0.00% |
REPL | 26.99% | $663.87M | +22.10% | 0.00% |
XPER | 26.67% | $355.04M | -29.60% | 0.00% |
IONS | 26.58% | $4.56B | -34.42% | 0.00% |
WRAP | 26.24% | $76.17M | -24.55% | 0.00% |
RVMD | 26.08% | $6.43B | +10.23% | 0.00% |
SW | 26.02% | $24.56B | +1.82% | 2.42% |
RARE | 25.83% | $3.27B | -24.87% | 0.00% |
LILA | 25.39% | $1.27B | -12.72% | 0.00% |
DNLI | 25.37% | $2.00B | -29.07% | 0.00% |
LILAK | 25.31% | $1.25B | -14.32% | 0.00% |
UTHR | 24.76% | $14.02B | +35.06% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
ES | <0.01% | $22.99B | +7.19% | 4.61% |
VSCO | -0.01% | $1.52B | +10.46% | 0.00% |
FIZZ | -0.04% | $3.90B | -9.84% | 0.00% |
BCH | 0.04% | $13.52B | +17.68% | 7.69% |
HY | 0.04% | $744.04M | -33.75% | 3.81% |
HLF | 0.04% | $893.57M | +8.48% | 0.00% |
SRRK | -0.07% | $3.08B | +113.66% | 0.00% |
SFL | 0.08% | $1.20B | -37.58% | 13.75% |
CVX | -0.08% | $291.28B | +3.76% | 4.19% |
WDS | -0.08% | $27.56B | -27.01% | 8.82% |
VTRS | 0.08% | $10.34B | -27.95% | 5.75% |
MED | -0.08% | $149.41M | -59.89% | 0.00% |
XPEL | -0.09% | $838.14M | -48.71% | 0.00% |
NOAH | 0.09% | $643.69M | -19.89% | 11.52% |
CPB | -0.09% | $11.75B | -8.27% | 3.73% |
AEP | -0.10% | $57.54B | +27.77% | 3.31% |
WSO | 0.10% | $21.04B | +20.47% | 2.18% |
AVAL | -0.10% | $1.03B | +17.09% | 3.89% |
DKL | 0.11% | $2.34B | +8.45% | 10.22% |
VLRS | 0.11% | $603.58M | -33.46% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
TAIL | -16.55% | $87.65M | 0.59% |
VIXY | -14.10% | $195.31M | 0.85% |
BTAL | -12.89% | $416.76M | 1.43% |
COM | -11.15% | $242.21M | 0.72% |
SGOL | -10.73% | $4.84B | 0.17% |
BAR | -10.67% | $1.05B | 0.1749% |
AAAU | -10.62% | $1.32B | 0.18% |
GLD | -10.52% | $93.86B | 0.4% |
OUNZ | -10.43% | $1.51B | 0.25% |
IAU | -10.42% | $42.85B | 0.25% |
GLDM | -10.40% | $13.28B | 0.1% |
TPMN | -10.30% | $33.32M | 0.65% |
BNO | -10.09% | $99.25M | 1% |
USO | -9.87% | $972.70M | 0.6% |
FTGC | -9.47% | $2.52B | 1.02% |
GSG | -9.29% | $1.05B | 0.75% |
USL | -9.18% | $47.77M | 0.85% |
DBC | -9.16% | $1.36B | 0.87% |
GLTR | -9.11% | $1.34B | 0.6% |
USCI | -9.08% | $240.82M | 1.07% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
TYA | <0.01% | $158.79M | 0.15% |
IBTO | -<0.01% | $334.00M | 0.07% |
SPTS | -0.01% | $5.97B | 0.03% |
TFI | -0.02% | $3.29B | 0.23% |
CMF | -0.04% | $3.77B | 0.08% |
SHM | 0.05% | $3.42B | 0.2% |
TDTF | -0.05% | $773.89M | 0.18% |
SHYM | -0.05% | $318.40M | 0.35% |
KMLM | -0.06% | $218.49M | 0.9% |
SCHP | 0.06% | $12.97B | 0.03% |
DTH | 0.08% | $371.46M | 0.58% |
HYD | -0.10% | $3.45B | 0.32% |
IBTM | 0.11% | $310.98M | 0.07% |
KBA | -0.12% | $188.42M | 0.56% |
EWJV | -0.14% | $308.09M | 0.15% |
GOVZ | 0.16% | $296.64M | 0.1% |
IBTP | -0.17% | $111.57M | 0.07% |
LIT | 0.19% | $908.37M | 0.75% |
ZROZ | 0.20% | $1.61B | 0.15% |
SUB | 0.21% | $8.76B | 0.07% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
LITB | -14.10% | $41.93M | -46.48% | 0.00% |
PRA | -13.45% | $1.20B | +85.99% | 0.00% |
KNOP | -13.23% | $260.66M | +43.40% | 1.46% |
FINV | -13.18% | $1.46B | +95.49% | 2.47% |
CHT | -12.89% | $30.46B | +0.31% | 3.71% |
TME | -12.35% | $10.12B | +26.82% | 0.97% |
GIFI | -11.51% | $109.03M | -12.81% | 0.00% |
CORT | -10.88% | $8.84B | +226.74% | 0.00% |
BBVA | -10.57% | $79.67B | +16.11% | 5.27% |
SWBI | -10.30% | $418.03M | -44.64% | 5.68% |
MKTX | -9.42% | $7.95B | -1.91% | 1.34% |
PHYS | -9.11% | - | - | 0.00% |
CEF.U | -8.85% | - | - | 0.00% |
CME | -8.78% | $94.61B | +23.82% | 3.89% |
TTE | -8.56% | $135.10B | -10.80% | 5.37% |
MUFG | -7.96% | $153.36B | +31.41% | 1.37% |
DNUT | -7.41% | $842.99M | -66.17% | 3.05% |
CARV | -7.35% | $7.31M | -8.92% | 0.00% |
MVO | -7.24% | $64.63M | -49.96% | 23.78% |
FMX | -7.20% | $20.58B | -20.18% | 4.82% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
PINK | 47.03% | $138.92M | 0.5% |
XBI | 39.97% | $4.76B | 0.35% |
GNOM | 38.06% | $47.13M | 0.5% |
IBB | 34.33% | $5.61B | 0.45% |
BBH | 31.42% | $358.88M | 0.35% |
FBT | 30.04% | $1.08B | 0.56% |
PTH | 29.98% | $107.91M | 0.6% |
CPSJ | 29.11% | $32.91M | 0.69% |
PBE | 29.07% | $224.98M | 0.58% |
CPRJ | 26.83% | $48.38M | 0.69% |
FXH | 25.88% | $954.59M | 0.62% |
HYBL | 25.25% | $354.79M | 0.7% |
UAUG | 25.23% | $148.46M | 0.79% |
BUFF | 24.88% | $574.99M | 0.89% |
HYGV | 24.83% | $1.40B | 0.37% |
RSPA | 24.46% | $292.67M | 0% |
PFUT | 24.34% | $321.92M | 0.65% |
ARKG | 24.30% | $936.86M | 0.75% |
VBK | 24.28% | $17.32B | 0.07% |
IVOG | 23.92% | $1.04B | 0.1% |
Yahoo
Sarepta Therapeutics (SRPT) shares fell nearly 7% in recent Thursday trading after media reports tha
SeekingAlpha
BioMarin Pharmaceutical Inc. has advancements in phenylketonuria treatment. Click to learn how Palynziq's success could expand BMRN's market in 2025.
Yahoo
Sarepta stock tumbled Thursday after European officials put all studies of the company's gene therapy, Elevidys, on hold.
Yahoo
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how therapeutics stocks fared in Q4, starting with Amgen (NASDAQ:AMGN).
Yahoo
BofA lowered the firm’s price target on Sarepta (SRPT) to $179 from $210 and keeps a Buy rating on the shares. Following the news of the departure of Peter Marks from the FDA’s Center for Biologics Evaluation and Research, the firm is lowering its Elevidys estimates by about 20% out of an abundance of caution. While it is early, and its conversation with Sarepta today indicates they don’t expect an immediate impact, BofA thinks the open seat introduces additional uncertainty in addition to the r
Yahoo
The major averages were mostly lower near noon, with the Dow up fractionally but the Nasdaq down nearly 250 points amid mounting concerns about President Donald Trump’s upcoming announcement of promised new tariffs. Meanwhile, the S&P 500’s early losses brought the index to its lowest level since September. Looking to commodities, gold prices are sharply higher, continuing their rally to over $3,150, while oil prices are also up over 2.5%. Get caught up quickly on the top news and calls moving s
Current Value
$57.221 Year Return
Current Value
$57.221 Year Return